Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BE...

Por Kim Young H, Hazama Megumi, Niimi Miyuki, Sakamori Yuichi, Tanaka Shiro, Yanagihara Kazuhiro
Publicado em 2011-05-01

Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BE...

Por Tanaka, Shiro, Sakamori, Yuichi, Niimi, Miyuki, Hazama, Megumi, Kim, Young H, Yanagihara, Kazuhiro
Publicado em 2011